BRCA2 and breast cancer: In a previous analysis of the population based Anglian Breast Cancer study (Antoniou et al, 2001), we have demonstrated that the familial aggregation of breast cancer can be adequately explained by the effects of BRCA1, BRCA2 and a polygenic component (i.e. a large number of low risk polymorphisms acting multiplicatively).